Chimeric antigen receptor natural killer cell therapy for solid tumors: Mechanisms, clinical progress, and strategies to overcome the tumor microenvironment

In a clinical review, researchers examine the development and clinical advancement of CAR natural killer cells for solid tumors. They discuss strategies to overcome the immunosuppressive tumor microenvironment, challenges inherent to allogeneic manufacturing, as well as future directions in the field.